C-Terminal Fragment, Aβ(39–42)-Based Tetrapeptides Mitigates Amyloid-β Aggregation-Induced Toxicity

[Image: see text] Since the introduction of acetyl cholinesterase inhibitors as the first approved drugs by the US Food and Drug Administration for Alzheimer’s disease (AD) in clinics, less than satisfactory success in the design of anti-AD agents has impelled the scientists to also focus toward inh...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ACS Omega
Auteurs principaux: Bansal, Sunil, Maurya, Indresh Kumar, Yadav, Nitin, Thota, Chaitanya Kumar, Kumar, Vinod, Tikoo, Kulbhushan, Chauhan, Virander Singh, Jain, Rahul
Format: Artigo
Langue:Inglês
Publié: American Chemical Society 2018
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6645473/
https://ncbi.nlm.nih.gov/pubmed/31459130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.8b01522
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires